Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, Citigroup Analyst Says

Key Points

• Citigroup increased the price target for Teladoc Health from $9.50 to $10.50, indicating a potential upside of 19.37% from the current stock price, while maintaining a "neutral" rating.
• The current consensus rating for Teladoc Health is "Hold" with an average price target of $9.97, reflecting mixed analyst opinions on the stock's performance.
• Despite reporting better-than-expected earnings, Teladoc Health has seen a negative net margin and a revenue decline of 1.6% year-over-year, leading to a forecasted loss per share in upcoming quarters.

Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective upped by stock analysts at Citigroup from $9.50 to $10.50 in a research report issued on Tuesday,Benzinga reports. The firm presently has a "neutral" rating on the health services provider's stock. Citigroup's price target would suggest a potential upside of 19.37% from the company's current price.

A number of other brokerages also recently commented on TDOC. Weiss Ratings restated a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday, October 8th. Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They set a "neutral" rating and a $10.00 price target on the stock. Zacks Research upgraded Teladoc Health from a "hold" rating to a "strong-buy" rating in a research note on Friday, October 10th. Finally, Evercore ISI raised their price target on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $9.97.

Teladoc Health Trading Down 2.0%

TDOC stock traded down $0.18 during midday trading on Tuesday, reaching $8.80. The company's stock had a trading volume of 3,125,785 shares, compared to its average volume of 6,917,405. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.55 billion, a price-to-earnings ratio of -7.38 and a beta of 1.90. The stock has a fifty day simple moving average of $7.99 and a two-hundred day simple moving average of $7.63. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm's quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities research analysts predict that Teladoc Health will post -1.16 EPS for the current year.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently modified their holdings of the business. Wealth Management Associates Inc. grew its stake in shares of Teladoc Health by 15.5% during the third quarter. Wealth Management Associates Inc. now owns 67,525 shares of the health services provider's stock worth $522,000 after acquiring an additional 9,075 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in shares of Teladoc Health by 61.8% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 150,075 shares of the health services provider's stock worth $1,160,000 after purchasing an additional 57,300 shares during the period. Strategic Planning Inc. acquired a new stake in shares of Teladoc Health during the third quarter worth about $93,000. Corient Private Wealth LLC lifted its holdings in shares of Teladoc Health by 30.4% during the second quarter. Corient Private Wealth LLC now owns 17,180 shares of the health services provider's stock worth $149,000 after purchasing an additional 4,004 shares during the period. Finally, Marex Group plc acquired a new stake in shares of Teladoc Health during the second quarter worth about $488,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.